ORTEXORTEX News
Tracking MCB? Get live short interest, options flow, and signals on ORTEX.Sign up free →
MC
Trader NoteMCB

MCB Posts Q3, and the Stock Jumps on Cue

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 21 Oct 2026, 20:20

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Metropolitan Bank Holding Corp. Q3 earnings landed Wednesday evening, and the story heading into Thursday is how quickly the defensive positioning that had built up ahead of the print has unwound.

Two prior notes documented the rotation. The put/call ratio climbed from below 0.65 in late September to a 52-week high of 1.85 last Friday, and short interest had risen roughly 13% over the past month. Both told the same story: options traders and short sellers were cautious going into the number. The stock's response has been the opposite. MCB gained 2.7% on Tuesday and is up about 3% on the week, closing at $88.87, while several close peers had a stronger session: UCB rose 5% on the day and DCOM gained 6%, suggesting a broader lift across regional banks rather than MCB-specific news driving the move.

The positioning story is now flipping. Short interest has eased, down 3% on the day and 1.5% on the week to 6.25% of the free float. The put/call ratio has pulled back from that 1.85 peak to 1.35, still above the 20-day average of 1.12 but no longer at an extreme. Borrow availability remains completely unconstrained at roughly 2,500%, meaning there are far more shares available to lend than are currently borrowed. Cost to borrow is 0.49%, down about 13% on the week and 21% over the past month. The lending market is signalling no squeeze pressure whatsoever. The defensive options bid was an earnings hedge, not a structural short.

The Street sits modestly bullish but not aggressively so. The mean analyst price target is around $105, implying roughly 18% upside from current levels, though the most recent moves cut that gap. Keefe, Bruyette & Woods maintained its Outperform rating after the prior quarter's print but trimmed its target from $120 to $110. UBS held Neutral with a $100 target. Both moves came in late July and are approaching the point where fresh post-Q3 revisions would be expected. At current levels, MCB trades on a PE of about 8.2x and at roughly 0.98x book, modest by most regional bank standards. The EPS surprise factor score ranks in only the 10th percentile, which has historically meant the bar for beating expectations is not especially demanding.

The FDIC call report data from the ORTEX Alt Data layer adds texture to the fundamental picture. Net loans and leases have risen for nine consecutive quarters, reaching $7.27 billion as of April 2026. Total assets have grown for six straight quarters to $8.86 billion. Neither dataset has yet been measured as a leading indicator of the company's reported figures, so these streaks are balance-sheet context rather than a forward read. The next earnings event is flagged for October 22, which is consistent with the Q3 print arriving this week.

On ownership, BlackRock raised its stake to 9.75% of shares as of September 30, adding 188,000 shares in the most recent quarter. That is the largest holder position and a meaningful increase. Wellington Management, by contrast, cut its position by roughly 180,000 shares in the June quarter. There is no 13D activist on the register, all filings are passive Schedule 13G. Director selling has dominated the insider ledger over the past 90 days, with director Robert Patent accounting for the bulk of roughly $1.24 million in net outflows, though CFO Daniel Dougherty made a discretionary open-market purchase of 1,000 shares at $89.98 in late July, right after the prior quarter's print. His current position is underwater on that trade, though only marginally.

The one reading that will reset the entire note is whether the Q3 numbers printed above or below the EPS line. That is what the remaining options skew and analyst target revisions will be priced around this week.

Stocks in this article

See the live data behind this article on ORTEX.

Open MCB on ORTEX →

How this article was generated

Generated
21 Oct 2026, 20:21
Data as of
21 Oct 2026, 20:20
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.